Humanin
Humanin is a revolutionary mitochondrial-derived peptide that extends lifespan and healthspan by protecting your cells from aging damage, boosting brain health, and optimizing metabolic function at the most fundamental level. It works by activating survival pathways in your mitochondria—your cells’ power plants—protecting them from oxidative stress and dysfunction that accelerates aging and disease.
Route
Subcutaneous injection
Dose range
500 mcg – 1 mg
Frequency
Once per day (subcutaneous)
Cycle length
20–30 days
Overview
Humanin is a revolutionary mitochondrial-derived peptide that extends lifespan and healthspan by protecting your cells from aging damage, boosting brain health, and optimizing metabolic function at the most fundamental level. It works by activating survival pathways in your mitochondria—your cells’ power plants—protecting them from oxidative stress and dysfunction that accelerates aging and disease. Research shows it reduces neuronal cell death by 30-40%, increases mitochondrial ATP production by 30%, and improves insulin sensitivity by 20-30%, creating a cellular environment where aging slows and resilience increases.
Beyond longevity, Humanin offers remarkable neuroprotection against Alzheimer’s and Parkinson’s by blocking beta-amyloid toxicity and supporting dopamine-producing neurons. It’s anti-inflammatory, reducing dangerous cytokines like IL-6 and TNF-α by 25-50%, while enhancing metabolic flexibility for healthier blood sugar control. Users report sustained energy, sharper cognition, and emotional resilience as systemic inflammation drops and mitochondrial function improves. Ideal for those over 40 seeking to slow aging, protect cognitive function, or combating metabolic challenges, Humanin represents a cellular-level approach to longevity that works independently of exercise or diet, though synergistically with both. Administered via injection, it’s a foundational anti-aging peptide addressing aging’s root mechanism.
Studied benefits
- A mitochondrial-derived peptide with potent cytoprotective (cell-protecting) effects
- It is researched for its ability to protect against neurodegeneration (Alzheimer’s), support cardiovascular health, and improve insulin sensitivity by protecting cells from oxidative stress
Reported side effects
- Preclinical data suggests it is well-tolerated
- however, human clinical data is currently limited
- Potential for minor localized irritation at the site of administration
Protocol
Dosing Schedule (Subcutaneous)
Educational reference only. Not medical advice. Research compounds are not approved for human use. Full disclaimer.
| Phase | Daily Dose (mcg) | Draw at 2.5 mg/mL | Log |
|---|---|---|---|
| Standard Research | 500 mcg | 20 units (0.2 mL) | + Log |
| Neuroprotective Study | 1,000 mcg (1 mg) | 40 units (0.4 mL) | + Log |
Frequency
Once per day (subcutaneous).
Timing
Consistent daily timing; morning administration is common.
Cycle length
20–30 days.
Unit calculator
Set your vial and water; the table above updates.
2.5 mg/mL
10 doses of 500 mcg per vial
Assumes a U-100 insulin syringe (100 units = 1 mL). Educational math only; verify every calculation yourself.
Context
Lifestyle considerations
Maintain a nutrient-dense, balanced diet rich in polyphenols and healthy fats to support the mitochondrial health and cytoprotective properties associated with this mitochondrial-derived peptide. Engage in regular, moderate aerobic exercise to stimulate natural mitochondrial biogenesis and enhance the peptide’s potential neuroprotective and cardioprotective effects. Ensure 7–9 hours of quality sleep to facilitate cellular repair and optimize the anti-apoptotic signaling pathways triggered by the compound. Practice stress management to reduce oxidative stress, which can otherwise accelerate mitochondrial decay and counteract the peptide’s role in promoting cellular longevity.
Evidence
Research summaries
Humanin: after the discovery
Findings: Protects brain cells from Alzheimer's damage and helps blood vessel cells too.
Humanin is a tiny protector made in our cells' power plants (mitochondria). It stops brain cells from dying when hit by bad proteins from Alzheimer's, like amyloid-beta, or faulty genes that cause the disease. It also saves cells in blood vessel walls from the same harm. This means Humanin could guard both brain and vessel health, which is huge for Alzheimer's patients where brain tangles and vessel issues team up to cause problems. Early lab work shows it blocks cell death pathways, opening doors to brain-saving drugs.
Read the study ↗Humanin is a novel neuroprotective agent against stroke
Findings: Shields brain from stroke damage, improves movement after brain blood clots.
In mice with stroke-like brain injury (no blood flow then back), Humanin (as HNG, a stronger version) cut brain cell death and swelling. Mice given it moved better, with less nerve damage and no extra cell suicide signals. It blocked a bad pathway called ERK that worsens injury, but left good ones alone. This suggests Humanin could be injected fast after stroke to save brain tissue and help recovery, like better walking or thinking, without messing other signals. A big win for stroke survivors.
Read the study ↗Humanin and Its Pathophysiological Roles in Aging
Findings: Guards heart after heart attacks, fights aging-related cell death.
Humanin pops up during stress like heart attacks to stop heart muscle cells from dying. In pig and mouse heart attack models, it lowered death proteins and saved heart tissue. It works by balancing cell life signals against death ones. For aging, where hearts weaken, this peptide could delay damage from low oxygen or stress. Studies show it helps insulin work better too, linking to diabetes prevention in older folks. Overall, it's like a built-in shield for age-worn organs.
Read the study ↗Humanin and diabetes mellitus: A review of in vitro and in vivo studies
Findings: Boosts insulin sensitivity, protects pancreas cells, delays diabetes start.
Humanin helps pancreas cells that make insulin survive stress, key for type 2 diabetes where those cells die off. Lab and animal tests show it cuts cell death, improves sugar handling, and slows diabetes onset. It acts like a shield under high sugar or fatty conditions, mimicking exercise benefits. For patients, this means better blood sugar control and fewer complications like nerve or eye damage. Reviews confirm it's promising for diabetes meds, especially as we age and cells weaken.
Read the study ↗Humanin: after the discovery
Findings: Protects brain cells from Alzheimer's damage and helps blood vessel cells too.
Humanin is a tiny protector made in our cells' power plants (mitochondria). It stops brain cells from dying when hit by bad proteins from Alzheimer's, like amyloid-beta, or faulty genes that cause the disease. It also saves cells in blood vessel walls from the same harm. This means Humanin could guard both brain and vessel health, which is huge for Alzheimer's patients where brain tangles and vessel issues team up to cause problems. Early lab work shows it blocks cell death pathways, opening doors to brain-saving drugs.
Read the study ↗Humanin is a novel neuroprotective agent against stroke
Findings: Shields brain from stroke damage, improves movement after brain blood clots.
In mice with stroke-like brain injury (no blood flow then back), Humanin (as HNG, a stronger version) cut brain cell death and swelling. Mice given it moved better, with less nerve damage and no extra cell suicide signals. It blocked a bad pathway called ERK that worsens injury, but left good ones alone. This suggests Humanin could be injected fast after stroke to save brain tissue and help recovery, like better walking or thinking, without messing other signals. A big win for stroke survivors.
Read the study ↗Humanin and Its Pathophysiological Roles in Aging
Findings: Guards heart after heart attacks, fights aging-related cell death.
Humanin pops up during stress like heart attacks to stop heart muscle cells from dying. In pig and mouse heart attack models, it lowered death proteins and saved heart tissue. It works by balancing cell life signals against death ones. For aging, where hearts weaken, this peptide could delay damage from low oxygen or stress. Studies show it helps insulin work better too, linking to diabetes prevention in older folks. Overall, it's like a built-in shield for age-worn organs.
Read the study ↗Humanin and diabetes mellitus: A review of in vitro and
More references (5)
- Humanin levels decline with age and in Alzheimer's disease, 2024
- The Molecular Structure and Role of Humanin in Tissue Regeneration, 2022
- Humanin-induced autophagy and lifespan extension in C. elegans, 2021
- Humanins: Neuroprotective and Cytoprotective Peptides, 2011
- The role of Humanin in the prevention of Alzheimer's dementia, 2003
Identification
Chemistry
- cas
- 330936-69-1 (primary)
- formula
- C₁₁₉H₂₀₄N₃₄O₃₂S₂ (reported variant: C₁₁₈H₂₀₀N₃₂O₃₅S)
- molecular weight
- 2687.2-2687.27 g/mol (free peptide); 2687.28 g/mol (common designation)
- sequence
- Met-Ala-Pro-Arg-Gly-Phe-Ser-Cys-Leu-Leu-Leu-Leu-Thr-Ser-Glu-Ile-Asp-Leu-Pro-Val-Lys-Arg-Arg-Ala (24 amino acids for cytoplasmic form); shorter 21-amino acid mitochondrial form also biologically active
- source
- Natural; encoded in the mitochondrial genome at the MT-RNR2 (16S rRNA) locus
- biosynthesis
- Ribosomal (mitochondrial); translated from mitochondrial 16S rRNA gene sequence; may also be expressed from nuclear mitochondrial DNA segments (NUMTs)
- type
- Linear peptide containing three-turn α-helix structure; no symmetry
Keep exploring
Related peptides
5-Amino-1MQ
5-amino-1-methylquinolinium · NNMTi
- Route
- Subcutaneous
- Dose
- 2.5 mg – 5 mg
- Cycle
- 10–20 days (based on a single 50 mg vial)
Adamax
- Route
- Subcutaneous
- Dose
- 100 mcg – 300 mcg
- Cycle
- 8–12 weeks
AICAR
Acadesine · AICA-Riboside
- Route
- Subcutaneous
- Dose
- 1 mg – 3 mg
- Cycle
- 8–12 weeks
ARA-290
ARA290 · Cibinetide
- Route
- Subcutaneous
- Dose
- 4 mg – 8 mg
- Cycle
- 4–8 weeks